#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovitis Metastases to peritoneum Wiskott-Aldrich syndrome Cholangiosarcoma Idiopathic inflammatory myopathy Synovial sarcoma metastatic Spina bifida Cytokine release syndrome Encephalitis autoimmune Extranodal marginal zone B-cell lymphoma (MALT type) Hypomagnesaemia Heart disease congenital Alternating hemiplegia of childhood Congenital disorder of glycosylation Autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    Hyperoxaluria – Diagnostics Ocular melanoma – Treatment Stevens-Johnson syndrome – Life with Disease Haemophilia B without inhibitors – Diagnostics Skin angiosarcoma – Basic Information Chondrosarcoma metastatic – Diagnostics Medulloblastoma recurrent – Diagnostics Myxofibrosarcoma – Life with Disease Leiomyosarcoma recurrent – Treatment Waldenstrom’s macroglobulinaemia refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Navitoclax Mirabegron Aavanc80-3'Hotof 534 Protein S Montelukast Sodium Bi 764532 Atacicept Topotecan Hydrochloride Caba-201 Lonapegsomatropin Temocillin Sodium Trospium Chloride Setanaxib Potato Starch CITRIC ACID ANHYDROUS Gallium (68Ga) Psma-R2 Elvn-002-1 STREPTOCOCCUS VIRIDANS Fluoroethyltyrosine F-18 More therapies…

    Learn about Your Condition

    Inguinal hernia Diverticulitis Acute leukaemia Depression Psoriasis Tachypnoea Small cell lung cancer Macular oedema Anal abscess Meniscus operation Hypotransferrinaemia Hepatic fibrosis Impaired gastric emptying Noonan syndrome Hidradenitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Bulgaria Denmark France Germany Ireland Italy +3

  • A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Overweight
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Enalapril Maleate
    • Finerenone
    France Greece Hungary Poland Slovakia Spain

  • A Study of Erenumab Compared to Placebo for Children and Teenagers With Chronic Migraine to Test How Well It Works and How Safe It Is

    Not recruiting

    3 1
    Investigated Drugs:
    • Erenumab
    Belgium Germany Hungary Italy Poland

  • Study of Erenumab Compared to Placebo for Children and Adolescents with Episodic Migraine to Reduce Monthly Migraine Days

    Not recruiting

    3 1
    Investigated Drugs:
    • Erenumab
    Belgium Germany Hungary Italy Poland Portugal +1

  • Study comparing two forms of ezetimibe and atorvastatin tablets in healthy volunteers to check if they work the same way in the body

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Atorvastatin Calcium
    • Ezetimibe
    • Atorvastatin
    Spain

  • Study comparing two formulations of sacubitril and valsartan tablets in healthy volunteers to check if they work the same way in the body

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Spain
Previous Page
1 … 933 934 935 936 937 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!